フロリダ州における膠腫の臨床試験
フロリダ州内の拠点で、膠腫に関する23件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Nemours Children's Clinic-Jacksonville, Jacksonville
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- 他4件
被験者募集中第1/2相
12 Months – 21 Years · 全性別 · 2026/10/01更新 · NCT05099003Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05030298Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Miami Cancer Institute, Miami
- Moffitt Cancer Center, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Nicklaus Children's Hospital, Miami
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/09/21更新 · NCT06838676Targeted Pediatric High-Grade Glioma Therapy
- University of Miami, Miami
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- University of Miami Hospital and Clinics, Miami
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Florida Health, Gainesville
- Mayo Clinic - Florida, Jacksonville
- University of Miami Health, Miami
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
被験者募集中第2相
3歳〜39歳 · 全性別 · 2026/08/24更新 · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- University of Florida, Gainesville
被験者募集中第1相
1歳〜25歳 · 全性別 · 2026/08/18更新 · NCT04485559A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Mayo Clinic in Florida, Jacksonville
被験者募集中
18歳以上 · 全性別 · 2026/08/10更新 · NCT07074756A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07464925A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- University of Miami Hospital and Clinics, Miami
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05188508A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- UF Health, Gainesville
被験者募集中第1相
4歳以上 · 全性別 · 2026/06/25更新 · NCT04573140STARLITE for Unresectable High-Grade Gliomas
- University of Miami, Miami
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/25更新 · NCT06428045PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial
- Lynn Cancer Institute at Baptist Health, Inc., Boca Raton
- Miami Cancer Institute at Baptist Health, Inc., Miami
被験者募集中
18歳以上 · 全性別 · 2026/06/01更新 · NCT06397560DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
- University of Miami Hospital, Miami
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/05/28更新 · NCT06264388A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/20更新 · NCT06326411Non-invasive Glioma Characterization Through Molecular Imaging
- University of Miami, Miami
被験者募集中
18歳以上 · 全性別 · 2026/04/20更新 · NCT03684109Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Jacksonville, Jacksonville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06482905DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- University of Miami, Miami
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/11更新 · NCT06504381Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
- University of Miami Hospital, Miami
被験者募集中第1/2相
18歳以下 · 全性別 · 2025/11/20更新 · NCT04299191ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。